Treatment of allosensitized patients receiving allogeneic transplantationStefan O. Ciurea, Kai Cao, Monzr M. Al Malki et al.|Blood Advances|2021Cited by 66
Functional SARS-CoV-2-specific T cells of donor origin in allogeneic stem cell transplant recipients of a T-cell-replete infusion: A prospective observational studyCorinna La Rosa, Don J. Diamond, Flavia Chiuppesi et al.|Frontiers in Immunology|2023Cited by 7
Adoptive transfer of functional <scp>SARS‐COV</scp>‐2‐specific immunity from donor graft to hematopoietic stem cell transplant recipientsCorinna La Rosa, Monzr M. Al Malki, Flavia Chiuppesi et al.|American Journal of Hematology|2022Cited by 5
Desensitization Therapy for Patients with DSA Receiving Haploidentical (Haplo) Stem Cell TransplantationStefan O. Ciurea, Kai Cao, Jun Zou et al.|Transplantation and Cellular Therapy|2020Cited by 0
FLAG-Ida-Venetoclax vs CLIA-venetoclax for relapsed and refractory AML during a fludarabine shortage: A single center experienceJose Tinajero, Karamjeet Sandhu, Amandeep Salhotra et al.|Journal of Oncology Pharmacy Practice|2025Cited by 0